Thomas J. G. Huot

Chief Operating Officer at Calysta, Inc.

Thomas J. G. Huot

Thomas J. G. Huot

Chief Operating Officer at Calysta, Inc.

Overview
Career Highlights

Calysta, Inc.

RelSci Relationships

990

Number of Boards

5

Birthday

1972

Age

48

Relationships
RelSci Relationships are individuals Thomas J. G. Huot likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer, Co-Founder at Genomatica, Inc.

Relationship likelihood: Strong

Executive Chairman at Genomatica, Inc.

Relationship likelihood: Strong

Former Director at Dow Chemical Company

Relationship likelihood: Strong

Executive Chairman at Calysta, Inc.

Relationship likelihood: Strong

Managing Partner at Flagship Pioneering

Relationship likelihood: Strong

Professor at UChicago Argonne LLC

Relationship likelihood: Strong

Co-Founder at Calysta, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Société d'Economie Mixte Genopole SAEM

Relationship likelihood: Strong

Managing Director at Expertise Beyond Borders BV

Relationship likelihood: Strong

Co-Founder at Future Ventures

Relationship likelihood: Strong

Paths to Thomas J. G. Huot
Potential Connections via
Relationship Science
You
Thomas J. G. Huot
Chief Operating Officer at Calysta, Inc.
Education
Ph.D. in Biochemistry & Molecular Biology

University College London (UCL) is a public research university in London, England, and the oldest and largest constituent college of the federal University of London. Founded in 1826 as London University, UCL was the first university institution established in London and the first in England to be entirely secular, to admit students regardless of their religion, and to admit women on equal terms with men. The philosopher Jeremy Bentham is commonly regarded as the spiritual father of UCL, as his radical ideas on education and society were the inspiration to its founders, although his direct involvement in its foundation was limited. UCL became one of the two founding colleges of the University of London in 1836. It has grown through mergers, including with the Institute of Neurology (in 1997), the Royal Free Hospital Medical School (in 1998), the Eastman Dental Institute (in 1999), the School of Slavonic and East European Studies (in 1999) and the School of Pharmacy (in 2012). UCL's main campus is located in the Bloomsbury area of central London, with a number of institutes and teaching hospitals located elsewhere in central London, and satellite campuses in Adelaide, Australia and Doha, Qatar. UCL is organised into 10 constituent faculties, within which there are over 100 departments, institutes and research centres. UCL has around 26,700 students and 11,025 staff and had a total income of £937 million in 2012/13, of which £335 million was from research grants and contracts. UCL has around 4,000 academic and research staff and 650 full professors, the highest number of any British university. UCL is responsible for several museums and collections in a wide range of fields across the arts and sciences, including the Petrie Museum of Egyptian Archaeology, a leading collection of Egyptian and Sudanese archaeology.

BS Biochemistry

University of Paris-Sud is a school in Orsay.

The University of London is a collegiate research university located in London, England, consisting of 18 constituent colleges, 10 research institutes and a number of central bodies. The nine largest institutions of the federal university, usually termed the colleges, are Birkbeck, Goldsmiths, King's College London, the London Business School, Queen Mary, Royal Holloway, SOAS, LSE and UCL. Formerly a constituent college, Imperial College London left the University of London in 2007.

Career History
Chief Operating Officer
2020 - Current

Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA.

Director
Tenure Unconfirmed

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Project Manager
Tenure Unconfirmed

Société d'Economie Mixte Genopole SAEM engages in the development of biotechnologies. It specializes in the research of genomics and genetics. The company was founded in 1998 and is headquartered in Evry, France.

Political Donations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thomas J. G. Huot. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thomas J. G. Huot's profile does not indicate a business or promotional relationship of any kind between RelSci and Thomas J. G. Huot.